Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Tranexamic Acid and Buccal Misoprostol for PPH Prevention
NCT03710304Completed
- Sponsor
- Aswan University Hospital
- Start
- Nov 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial of tranexamic acid and misoprostol in postpartum hemorrhage (PPH) (2 arms), sponsored by Aswan University Hospital. Primary endpoint: Number of participants requiring additional pharmacological uterotonic at 24 hours. Started Nov 2018; status: completed.
02
Drugs
tranexamic acidmisoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT03710304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03710304.